CPhI Pharma Awards Showcase Industry Drivers

AsiaNet 54761

FRANKFURT, Germany, Oct. 24 / PRN=KYODO JBN/ --

    - API Corporation, E-Pharma Trento and Camurus- the 2013 winners

    The CPhI Pharma Awards 2013 winners were announced live at the awards

ceremony- day one at CPhI Worldwide [http://www.cphi.com ]. Honouring

outstanding developments from some key industry players, the awards highlighted

ever-advancing market innovations, fundamental to driving growth throughout

global pharma.

    (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

    This year the event, which is the foremost opportunity to recognise

outstanding achievement amongst industry peers and pharma leaders, had three

categories, designed to recognize innovation in formulation, process

development, and packaging. A record-breaking 44 entries were received, 13 for

formulation, 18 for process development, and 13 for packaging- a total of nine

finalists were chosen, three in each of the categories:

    Best Innovation in Process Development

    The 2013 winner for Best Innovation in Process Development was deservingly

won by API Corporation, acknowledging the Company's leading catalytic system

for C-H activation. Many drug substances' pharmaceutical activity is exerted by

a structural motif called a biaryl unit. Current synthesis, however, requires

large amounts of hazardous chemicals. API's technology conceptually addresses

this issue as a catalytic system of C-H activation that both drives down costs

and provides an environmentally friendly process. Currently, this technology

has been applied to the commercial synthesis of angiotensin II receptor

blockers.

    Best Innovation in Formulation

    The CPhI Pharma Award for Best Innovation in Formulation was received with

overwhelming reception as Camurus was announced as this year's winner. Camurus

was acknowledged for their fluid Injection depot that delivers therapeutic

doses over extended periods - adjustable from days to months - from a single

injection. Setting the depot aside from other parenteral technologies of its

kind, this fluid injection depot is comprised of a lipid-based liquid solution

that transforms into a liquid crystal gel matrix in situ on contact with minute

quantities of aqueous fluid at the site of injection. The drug becomes

effectively encapsulated and is released in a controlled manner. This provides

key benefits compared to other associated market products, by reducing the

typical complex manufacturing, reconstitution before administration,

refrigerated storage or limited compatibility with biomolecules- clearly

highlighting these benefits, the technology has already been licensed to drug

giant Novartis.

    Best Innovation in Packaging

    Of the three innovative Packaging finalists, E-Pharma Trento were the

winners of the evening, with their strengthened blister pack to package solid

pharmaceutical and nutraceutical forms, providing especial use for fragile

tablets. Made of three layers (Al - PVC - PA/Al/PVC) that make the capsule

packaging more rigid, it allows the user to push-through tablets without

damaging them. The award will help the company "push the product," Silvia

Boschetti R&D manager at E-Pharma Trento commented. She continued: "E-Pharma

Trento's packaging technology offers an alternative that addresses the

disadvantages of existing fragile tablet packaging."

    Chris Kilbee, Group Director Pharma at UBM Live, extended his

congratulations to all the finalists and the evening's winners and commented:

"Our Pharma Awards are an exceptional platform, providing the opportunity to

highlight innovations within the industry that are set to drive the

pharmaceutical marketplace. As an example, one of our winning technologies has

already received significant interest by big pharma, so it is with delight that

we are able to showcase such leading innovations. We are already looking

forward to next year's event where we hope to see yet more industry-driving

award entries".

    Notes to editors

    About CPhI

    CPhI drives growth and innovation at every step of the global

pharmaceutical supply chain from drug discovery to finished dosage. Through

exhibitions, conferences and online communities, CPhI brings together more than

100,000 pharmaceutical professionals each year to network, identify business

opportunities and expand the global market. CPhI hosts events in Europe, China,

India, Japan, Southeast Asia, Russia and South America co-located with ICSE for

contract services, P-MEC for machinery, equipment & technology, InnoPack for

pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer

& supplier directory at CPhI-Online.com and hosts a global community with news

and analysis at PharmaEvolution.com.

    For more information visit: http://www.cphi.com

    The UBM Live annual schedule of Pharmaceutical events also includes CPhI

Worldwide, ICSE, P-MEC Europe and InnoPack (22-24 October, 2013 at Messe

Frankfurt, Germany); CPhI and P-MEC India (3-5 December, 2013 at the Bombay

Exhibition Centre in Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan

(9-11 April, 2014 in Tokyo); CPhI Russia and IPhEB (16-17 April, 2014 in St

Petersburg, Russia); CPhI, P-MEC and Innopack South East Asia (20-22 May, 2014

in Jakarta, Indonesia); CPhI Istanbul (4-6 June, 2014, Turkey) and CPhI, Hi and

Fi, ICSE, P-MEC, BioPh and LabWorld China (26-28 June, 2014 at SNIEC, Shanghai,

China).

    About UBM Live

    UBM Live connects people and creates opportunities for companies across

five continents to develop new business, meet customers, launch new products,

promote their brands, and expand their market. Through premier brands such as

TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete

Show, and many others, UBM Live exhibitions, conferences, awards programs,

publications, Websites, and training and certification programs are an integral

part of the marketing plans of companies across more than 20 industry sectors.

    For media enquiries, please contact: Alex Heeley or Tristan Jervis, De

Facto Communications, T: +44-(0)207-203-6745 / 6740, E: a.heeley@defacto.com /

t.jervis@defacto.com

SOURCE: UBM Live